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ABSTRACT The designed peptide 1-methyliaole-2-
carboxamide netropsin (2-ImN) binds specifically to the se-
quence 5'-TGACT-3'. Direct evidence fromNMR spectroscopy
is presented that this synthetic ligand binds DNA as a 2:1
complex, which reveals that the structure is an antiparallel
dimer in the minor groove ofDNA. This is in contrast to the 1:1
complexes usually seen with most crescent-shaped minor
groove binding molecules targeted toward A+T-rich tracts but
reminiscent of a dimeric motif found for distamycin at high
concentrations. These results suggest that sequence-dependent
groove width may play an important role in allowing an
expanded set of DNA binding motifs for synthetic peptides.
The natural products netropsin and distamycin A are crescent
shaped di- and tripeptides, respectively, that bind in the
minor groove ofDNA at sites of four or five successive APT
base pairs (1-8). The structures ofa number ofpeptide-DNA
complexes have been determined by x-ray diffraction (4-6)
and NMR spectroscopy (7, 8). Analysis of these structures
has led to the conclusion that hydrogen bonding, van der
Waals contacts, and electrostatics all contribute to the bind-
ing affinity and specificity. The minor groove of sequences
containing APT base pairs is deeper than that of G-C pair
sequences due to the absence of the amino group of guanine.
It has been found that the width of the minor groove of some
of these A+T-rich sequences is narrower than standard
B-DNA (9). The two or three N-methylpyrrole-carboxamides
twist in a screw sense to match the walls of the minor groove,
giving a favorable shape complementarity for the ligand
(4-6).
Although there has been some encouraging success with
regard to the design and synthesis ofpeptide analogs that bind
larger sequences of pure A+T-rich double-stranded DNA
(10-14), there has not been corresponding success in the
development of well-understood GC recognition for targets
with mixed A*T and G*C sequences (15-17). Attachment of
pyridine-2-carboxamide to the amino terminus of the dipep-
tide bis-N-methylpyrrolecarboxamide affords the tripeptide
pyridine-2-carboxamide netropsin (2-PyN), which binds spe-
cifically the sequence 5'-TGACT-3' as well as the family of
5'-(A T)5-3' sequences (18, 19). Although this molecule was
designed to bind sequences of the type 5'-(G-C)(A-T)3-3' in a
single orientation preference, affinity cleaving experiments
revealed that the 2-PyN-5'-TGACT-3' complex is composed
of two equivalent orientations (19, 20). Models of a 1:1
ligand-DNA complex seemed inadequate for rationalizing
either the approximate twofold symmetry of the complex or
the recognition of G*C base pairs in both the second and
fourth positions of the 5'-TGACT-3' site (18). In an effort to
2-PyN 2-IimN
explore the structural limitations for 2-PyN, pyridine has
been replaced by N-methylimidazole to afford 1-methylimi-
dazole-2-carboxamide netropsin (2-ImN) (19). From foot-
printing analysis, this molecule binds the sequence 5'-
TGACT-3' more strongly than 5'-(AT)s-3' tracts (19, 20). In
addition, from affinity cleaving, the complex of 2-ImN-5'-
TGACT-3' is composed of two equivalent orientations (19,
20).
Although the x-ray structure of distamycin bound to the
sequence 5'-AAATTT-3' reveals a 1:1 complex (6), recent
NMR studies indicate that at high concentration (2.0-4.0
mM), distamycin is also capable of binding A+T-rich DNA
to form a 2:1 complex (21, 22). Such a 2:1 complex would
explain the affinity cleavage data and the sequence specificity
of 2-PyN and 2-ImN (19, 20). We describe here direct
structural studies by NMR spectroscopy on the complex
formed upon binding of 2-ImN to the oligonucleotide duplex
d(GCATGACTCGG)*d(CCGAGTCATGC).
MATERIALS AND METHODS
Synthesis of 2-ImN. 2-ImN was prepared from N-methyl4-
(N-methyl-4-nitropyrrole-2-carboxamide)pyrrole-2-carbox-
ylic acid (23) in four steps. Full synthetic details will be
published elsewhere (20).
Sequence Specificity of 2-ImN. The binding of 2-ImN was
compared with the distamycin analog, tris-N-methylpyrrole-
carboxamide (P3) (3), on the 517-base-pair EcoRI/Rsa I
Abbreviations: 2-PyN, pyridine-2-carboxamide netropsin; 2-ImN,
1-methylimidazole-2-carboxamide netropsin; NOESY, nuclear
Overhauser effect spectroscopy.
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restriction fragment of plasmid pBR322 by footprinting and
affinity cleaving analyses. From footprinting analysis, at 2
,uM concentration, the distamycin analog P3 binds to the
5-base-pair sites, in the following order ofdecreasing affinity:
5'-TTTTT-3' > 5'-AATAA-3' > 5'-TTAAT-3' >> 5'-
TGTCA-3'. 2-ImN (at 10 juM concentration) was found to
bind the 5-base-pair sites in the following order of decreasing
affinity: 5'-TGTCA-3' >> 5'-TTTTT-'3 > 5'-AATAA-3'
5'-TTAAT-3'. Affinity cleaving experiments with 2-ImN-
EDTA-Fe reveals that the synthetic peptide binds in two
equivalent orientations to the 5'-TGTCA-3' site (20).
Sample Preparation. NMR samples were prepared by dis-
solving the undecamer in 0.25 ml of 20 mM sodium phosphate
buffer (pH 7.0) and then lyophilizing to dryness. For exper-
iments carried out in 2H2O, the solid was lyophilized twice
from 99.9% 2H2O (Cambridge Isotope Laboratories, Cam-
bridge, MA) and finally redissolved in 0.5 ml of 99.99%o 2H2O
(Cambridge Isotope Laboratories). For experiments in H20,
the solid was redissolved in 90% H20 and 10% 2H20 to a final
vol of 0.5 ml.
A stock solution of 2-ImN HCl was prepared by dissolving
2.5 mg of the ligand in 150 ,ul of 99.99% 2H2O containing 10
mM sodium phosphate buffer (pH 7.0). The concentration of
the stock solution was determined to be 32 mM by UV
absorbance at 302 nm (E = 3.5 x 104 M-1-cm-'). Extinction
coefficients for d(GCATGACTCGG) and d(CCGAGT-
CATGC) were calculated to be 1.05 x 105 M-1-cm-1 and 1.02
x 105 M-'.cm-1, respectively (24). The concentration of the
double-stranded DNA sample was determined to be 2 mM by
UV absorbance at 260 nm at 80°C.
One-Dimensional NMR Titration. 2-ImN-HCl was titrated
into the NMR sample containing the DNA in 0.25 mol
equivalents per addition. One-dimensional spectra were ac-
quired at 25°C by using 4096 complex points, 128 scans, and
a spectral width of 6024 Hz. A presaturation pulse was
applied during the 2.0-sec recycle delay to suppress the
residual 1H2HO resonance.
Two-Dimensional Nuclear Overhauser Effect Spectroscopy
(NOESY) Spectra. NOESY spectra in 2H20 were acquired at
15°C using the standard time-proportional phase incremen-
tation (TPPI) pulse sequence (25). The spectra were collected
with 1024 complex points in t2 using a spectral width of 5000
Hz (500 MHz) or 6024 Hz (600 MHz) and a mixing time of 200
msec. Typically, 512 tj experiments were recorded and
zero-filled to 1 K. For each tj value 64 scans were signal
averaged using a recycle delay of 2 sec. A presaturation pulse
was applied during the recycle and mixing periods to sup-
press the residual 1H2HO resonance.
NOESY spectra in water were acquired at 15°C, replacing
the last 900 pulse by 1:1 to suppress the solvent signal, using
the pulse sequence delay -90
-t1-90'.,-Tmix-90,-A&1-90'0 t2(26). Phase-sensitive detection was accomplished with TPPI.
The spectra were collected with 2048 complex points in t2
with a spectral width of 13,514 Hz and mixing times of 100 and
200 msec. Typically, 547-567 tj experiments were recorded
and zero-filled to 2 K. The delay period A"l was calibrated to
give optimum excitation in the imino region of the 1H
spectrum (11-13 ppm) with a single null at the water reso-
nance.
The data were processed with FTNMR software (Hare
Research, Woodinville, WA) on a Vax 11/785 computer or
with FELIX software (Hare Research) on a Silicon Graphics
IRIS/4D workstation. The two-dimensional NOESY data
were apodized with a skewed sine bell function in both
dimensions (800-1600 points, phase 60°, skew 0.5 in t2;
512-567 points, phase 60°, skew 0.7 in tj). The first row of the
data matrix was multiplied by 0.5 prior to Fourier transfor-
mation in tj to suppress t: ridges.
Distance Constraints. Intermolecular distance constraints
were generated from the volume integrals of the crosspeaks
in the H20 NOESY spectra acquired at mixing times of 100
and 200 msec. Volume integrals were measured for each
mixing time using FELIX software. The crosspeak volumes
were scaled according to Vc., = V~bd/sin(AwcT), where Vc.,
is the corrected crosspeak volume, V~bs is the measured
crosspeak volume, X is the delay adjusted to optimize exci-
tation of the region of interest, and Acw is the difference in
frequency between the null and the crosspeak of interest in
F2. The crosspeak volumes were classified semiquantita-
tively into three categories: strong (<2.5 A), medium (be-
tween 2.5 and 3.7 A), or weak (>3.7 A) relative to the volume
integrals of the cytosine H5-H6 crosspeak volumes at each
mixing time. In all, 34 intermolecular ligand-DNA con-
straints and 5 intermolecular ligand-ligand constraints were
used.
Structure Refrement. The initial structure for refinement
calculations was a duplex of sequence d(GCATGACTCGG)-
d(CCGAGTCATGC) constructed using the Biopolymer
module of InsightIl (Biosym Technologies, San Diego) with
standard B-DNA helical parameters. For the ligands, the
coordinates for the two distamycin molecules in the energy
minimized NMR structure of the 2:1 complex with
d(CGCAAATTGGC)-d(GCCAATTTGCG) (21) were read
into InsightIl. Using the Builder module of InsightII, the
distamycin molecules were transformed into 2-ImN mole-
cules. The Silicon Graphics workstation facilitated a simple
docking procedure to produce the starting coordinates for the
ligand dimer-DNA complex. Energy minimizations were
performed by using the Discover module of InsightIl. NOE
distance constraints were incorporated into the structure
prior to each simulation. A cutoff distance of 15 A was used
for nonbonded interactions and the neighbor list was regen-
erated every 20 time steps. A distance-dependent dielectric of
the form e = R was used to account for solvent effects. The
energy of the complex was minimized initially by using 100
steps of a steepest descent algorithm and further by using
15,000 steps of conjugate gradient minimization with anNMR
force constant of 50 (kcal/mol)/A to an rms derivative of
<0.01 (kcal/mol)/A.
RESULTS
Titration of 2-ImN. The results of the titration of 2-ImN
into an NMR sample of the duplex d(GCATGACTCGG)-
d(CCGAGTCATGC) are shown in Fig. 1. The individual
aromatic base protons of the central 3-base-pair site in the
free duplex are indicated by stars. These were assigned in the
NOESY spectrum of the free duplex by standard sequential
methods (27). Upon addition of substoichiometric amounts of
2-ImN, the NMR spectrum increases in complexity as evi-
denced by a doubling of the number of resonances. At a
ligand/DNA ratio of 0.5:1, new resonances appear (squares)
whose intensities are one-third the intensity of the free DNA
signals. At a ligand/DNA stoichiometry of 1:1, the ratio of
signal intensities of complexed DNA to free DNA is 1:1,
indicating that one-half of the DNA exists as complex.
Subsequent additions of 2-ImN to the sample act solely to
increase the intensities of the signals from complexed DNA
as well as the signals from bound ligand. At a ligand/DNA
ratio of 2:1 only one set of DNA resonances and one set of
bound ligand resonances are present, implying that a single
ligand-DNA complex has been formed. Furthermore, a com-
parison of the peak intensities of complexed to free DNA as
a function of increasing concentration of ligand shows that
this single complex has a stoichiometry of 2:1. The sharpness
of the ligand and DNA signals throughout the titration
indicates that the ligands are in slow exchange on the NMR
time scale.
Signal Assignments. Two-dimensional NOESY spectra of
the complex in 2H20 were acquired at two equivalents of
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FIG. 1. Aromatic region of NMR spectra acquired at several
points in a titration of d(GCATGACTCGG)-d(CCGAGTCATGC)
with 2-ImN at 25TC.
added ligand. Each aromatic base proton (H8 of purines, H6
ofpyrimidines) was assigned through its connectivity to C1'H
of its own sugar and the C1'H of its 5' neighbor. Assignment
ofthe imino protons in the H20 NOESY by standard methods
(28) facilitated the assignment of the adenine C2H protons in
the complex. The amino NH2 protons of G5 and G16 were
assigned via their connectivities to ligand pyrrole H3 and
imidazole H4 protons. Ligand amide NH protons, pyrrole
H3, and imidazole H4 protons were assigned by intramolec-
ular connectivities among these protons in the NOESY
spectrum of the complex in H20. Ligand methylene protons
(C18) were assigned via intermolecular contacts to the imid-
azole H4 proton on the opposite ligand of the 2:1 complex.
Intermolecular Contacts. The NOESY spectrum of the 2:1
complex in H20 is shown in Fig. 2. The spectrum contains
numerous intermolecular contacts that enable the placement
of the ligands on the DNA. The ligand-ligand and ligand-
DNA contacts are summarized in Table 1. Strong NOE
crosspeaks between the imidazole H4 protons and the NH2
protons ofG5 and G16, as well as between the H3-2 and H3-3
pyrrole protons of both ligands and the C2H protons of A6
define the orientations ofthe ligands. The ligands stack on top
of one another in an antiparallel fashion. These intermolec-
ular contacts are shown schematically in Fig. 3. Further
contacts between ligand amide protons and DNA protons
along the minor groove of the central 5-base-pair binding site
confirm the placement of the ligands. The relative position of
the ligands with respect to one another is also confirmed by
five intermolecular ligand-ligand contacts.
Molecular Modeling. The intermolecular contacts listed in
Table 1 plus ligand intramolecular contacts were used as
constraints in the energy minimization procedure. The re-
sulting structure is presented in Fig. 4. The charged end of
each 2-ImN molecule lies deep in the minor groove, providing
favorable contributions to the total free energy of the struc-
ture. For ligand 1, putative hydrogen bonds are formed
between NH-1 and N3 of A6, NH-2 and 02 of C7, NH-3 and
02 ofT8, and between N3 ofthe imidazole and theNH2 group
ofG5. Analogous hydrogen bonds are found for ligand 2, with
the imidazole N3 hydrogen-bonded to the NH2 group of G16.
The stacking of the ligand molecules with respect to one
another, as found by molecular modeling, is similar to the
staggered antiparallel arrangement found in the 2:1 complex
formed between distamycin and d(CGCAAATTGGC)-d(GC-
CAATTTGCG) (21).
DISCUSSION
Titration of the duplex d(GCATGACTCGG)-d(CCGAGT-
CATGC) with 2-ImN yields only one set of new resonances
in the one-dimensional NMR spectrum. Analysis of two-
dimensional NMR spectra reveals that these resonances are
associated with a 2:1 ligand-DNA complex. Thus, even at
low ligand/DNA stoichiometries (e.g., 0.25:1) dimeric bind-
ing is dominant, indicating that the two ligands bind with high
cooperativity. In contrast, studies of the complexes formed
between distamycin and the 5'-AAATT-3' and 5'-
AAATTT-3' duplexes do not show evidence for the 2:1
binding mode until 0.5-0.75 equivalent of ligand has been
added (21, 22). Replacement of A-T base pairs with
inosine-cytosine (IC) base pairs, which present the same
functional groups on their minor groove surfaces, affords
highly cooperative dimeric binding of distamycin to the
sequence d(CGCIIICCGGC)-d(GCCIICCCGCG) (29). If
G-C- or I-C-bearing DNA sequences have inherently wider
minor grooves, formation of 2:1 complexes on ligand binding
may be favored as a result of a reduction in the energy cost
to accommodate the second ligand. In addition, single ligand
binding modes for such sequences would be disfavored if
their grooves were not capable ofclamping down sufficiently
on one ligand to maximize the van der Waals contacts
necessary for binding.
The ligand binding sites of the 2-ImN complex are defined
by the intermolecular ligand-DNANOEs given in Table 1. For
ligand 1, the pyrrole protons H3-2 and H3-3 give strong NOEs
to C2H of A6 and C1'H of C7, and NH2 of G16 and C1'H of
T8, respectively. The imidazole H4 proton of ligand 1 has a
strong NOE to NH2 of G5. Therefore, the imidazole-pyrrole-
pyrrole ring system of ligand 1 spans the G5-A6-C7 sequence
with the imidazole ring oriented to the 5' side of the strand.
Likewise, for ligand 2, H3-2 and H3-3 pyrrole protons are
proximal to C2H ofA6 and C1'H ofC18, and toNH2 ofG5 and
C1'H of A19, respectively. The imidazole H4 proton of ligand
2 gives a strong NOE to NH2 of G16. These data indicate that
the imidazole-pyrrole-pyrrole ring system of ligand 2 spans
the same G5-A6-C7 sequence as ligand 1, but in the opposite
orientation. NOEs between CH2 of C18 on ligand 1 and
imidazole H4 on ligand 2, as well as between CH2 of C18 on
ligand 2 and imidazole H4 on ligand 1, confirm the orientations
of the ligands on the DNA and relative to one another. These
data indicate that the dimeric binding site is in the minor
groove of the central portion of this DNA oligomer.
The stability ofthe 2-ImN-DNA complex is determined by
several factors. The amide NH protons contribute favorably
to the binding energy through hydrogen bond formation to
thymine 02 and adenine N3 atoms. Pyrrole H3 protons and
the imidazole H4 proton form close van der Waals contacts
with sugar C1'H and adenine C2H protons of the DNA. The
positively charged N,N-dimethylammonium group facilitates
the attraction of the ligand to DNA. Stacking of the conju-
gated ring systems of the ligands in the 2:1 complex provides
additional binding energy. Maximizing the contacts that
provide the binding energy may require some distortion ofthe
duplex and the concomitant energetic penalty. From the
NMR studies presented here and chemical protection exper-
iments, there is no strong evidence for major distortions of
the DNA helix or conformation as a result of 2-ImN binding
to 5'-TGACT-3' (19).
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FIG. 2. Expansion of the aromatic and amide region of a NOESY spectrum of the 2:1 2-ImN-d(GCATGACTCGG)-d(CCGAGTCATGC)
complex (in 90% H20/110 2H20; 15°C; mixing time, 200 msec). Sequential aromatic to C1'H connectivities for the 5'-TGACT-3' strand are
shown as solid lines; those for the 5'-AGTCA-3' strand are shown as dashed lines. Crosspeaks are labeled according to their chemical shifts
along w (vertical axis, label beside the peak) and along w2 (horizontal axis, label above or below the peak). Labeling conventions for ligands
1 and 2 are NH- for amide hydrogens, H3- for pyrrole hydrogens, and H4-1 for the imidazole hydrogen, numbered from the imidazole end to
the ammonium end.
The most striking feature of the (2-ImN)2--5'-TGACT-3'
complex is the specific recognition of both G-C and AT base
pairs. Molecular modeling of the 2:1 complex suggests that
Table 1. Ligand-DNA and ligand-ligand intermolecular contacts
Ligand 1 DNA Ligand 2
H4-1
NH-1, H4-1
NH-1
NH-1, H3-2
NH-2, H3-2
NH-2, H3-3
H3-3
C(18)H
H3-2
H4-1
NH1
H3-2
Ligand-DNA
A19 C2H
A19 C1'H
G5 C1'H
G5 NH2
C18 C1'H
T17 C1'H
A6 C1'H
A6 C2H
C7 C1'H
G16 NH2
G16 C1'H
T8 C1'H
Ligand-ligand
NH-3
NH-3, H3-3
NH-2, H3-3
NH-2, H3-2
NH-2
NH-2, H3-2
NH-1, H4-1
H4-1
H4-1
H3-2
C(18)H
H3-2
NH-2
the imidazole nitrogen (N3) proximal to the 2-amino group of
guanine affords a hydrogen bond that contributes to the
%N<HC1
'-C
FIG. 3. Schematic of selected intermolecular NOEs between
2-ImN and d(GCATGACTCGG)-d(CCGAGTCATGC).
Contacts were identified in the H20 NOESY acquired at 200 msec
mixing time.
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FIG. 4. van der Waals surface representation of the 2-ImN-
d(GCATGACTCGG)-d(CCGAGTCATGC) complex obtained by en-
ergy refinement using semiquantitative distance constraints derived
from NOESY.
stability of the complex. There may be an energetic price for
this recognition if the crescent-shaped 2-ImN does not sit
deeply in the minor groove of the sequence 5'-TGACT-3'.
Undoubtedly, this antiparallel side-by-side 2:1 peptide-
DNA complex broadens the structural repertoire beyond 1:1
complexes for design considerations of sequence-specific
minor groove binding molecules. The generality of this motif
for the sequence-specific recognition of a large number of
DNA sequences remains to be seen. We are encouraged by
the recent simultaneous finding that a different distamycin
analog containing a central imidazole binds the sequence
5'-AAGTT-3' as a 2:1 complex (30). Dimeric motifs seem
unlikely to be limited to N-methylpyrrole-carboxamide ana-
logs. We note that chromomycin, an oligosaccharide chro-
mophore, binds in the minor groove as a 2:1 complex (31).
Perhaps additional classes of side-by-side binders can be
constructed that will act as shape-selective calipers for se-
quence-dependent minor groove width.
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